
NuVasive NUVA
Quarterly report 2023-Q2
added 08-02-2023
NuVasive Total Liabilities 2011-2026 | NUVA
Annual Total Liabilities NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 970 M | 873 M | 840 M | 870 M | 587 M | 695 M | 575 M | 626 M | 619 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 970 M | 575 M | 740 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
Zimmer Biomet Holdings
ZBH
|
8.89 B | $ 88.57 | -0.65 % | $ 18 B | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Accuray Incorporated
ARAY
|
389 M | $ 0.4 | 4.21 % | $ 41.1 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Abbott Laboratories
ABT
|
36.6 B | $ 103.99 | -0.55 % | $ 181 B | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Align Technology
ALGN
|
2.36 B | $ 166.38 | -6.17 % | $ 12.5 B | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Alphatec Holdings
ATEC
|
126 M | $ 10.93 | -5.12 % | $ 1.64 B | ||
|
AxoGen
AXGN
|
92.8 M | $ 31.28 | -3.01 % | $ 1.44 B | ||
|
Bruker Corporation
BRKR
|
3.99 B | $ 33.72 | -4.58 % | $ 5.02 K | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
16.7 B | $ 69.17 | -1.43 % | $ 102 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 9.07 | -3.41 % | $ 257 M | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 34.58 | -5.62 % | $ 1.07 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Electromed
ELMD
|
10.6 M | $ 24.55 | 0.41 % | $ 208 M | ||
|
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.59 | -1.18 % | $ 32.1 M | ||
|
Aethlon Medical
AEMD
|
2.24 M | $ 2.15 | -5.29 % | $ 3.36 M | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 79.34 | -3.36 % | $ 46.4 B | ||
|
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | ||
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 11.2 | -1.84 % | $ 1.51 B | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.52 | -5.08 % | $ 364 M | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.92 | -4.48 % | $ 1.17 M | ||
|
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | ||
|
Inogen
INGN
|
106 M | $ 6.19 | -4.77 % | $ 165 M | ||
|
IRIDEX Corporation
IRIX
|
24.9 M | $ 0.99 | -26.67 % | $ 16 M | ||
|
Integer Holdings Corporation
ITGR
|
1.66 B | $ 85.33 | -1.73 % | $ 2.96 B | ||
|
Myomo
MYO
|
27.2 M | $ 0.7 | 2.32 % | $ 29.3 M | ||
|
Penumbra
PEN
|
399 M | $ 335.1 | -0.39 % | $ 13 B | ||
|
LivaNova PLC
LIVN
|
1.41 B | $ 61.85 | -2.83 % | $ 3.37 B | ||
|
LENSAR
LNSR
|
47.7 M | $ 6.07 | 9.96 % | $ 69.9 M | ||
|
Inspire Medical Systems
INSP
|
126 M | $ 50.13 | -0.63 % | $ 1.47 B | ||
|
Medtronic PLC
MDT
|
43.4 B | $ 87.14 | 0.21 % | $ 112 B |